These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5736035)

  • 1. [Effect of sulfonylureas on lipid levels in diabetic patients].
    Sgambato S; Cristiano L; Torella R
    Rass Int Clin Ter; 1968 Apr; 48(8):455-62. PubMed ID: 5736035
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Free fatty acid and triglyceride content of the blood in newly-detected diabetes mellitus with prolonged preservation of normoglycemia as a result of diet therapy in combination with sulfanilamide antidiabetic preparations].
    Bogatyreva ShI; Dzeranova NIa; Zaripova ZKh
    Probl Endokrinol (Mosk); 1973; 19(1):3-7. PubMed ID: 4698453
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
    Fidel J; Nelken L
    Isr J Med Sci; 1974 Jul; 10(7):702-6. PubMed ID: 4852026
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
    Fedeli S; Maglia A
    Arch Sci Med (Torino); 1977; 134(1):33-8. PubMed ID: 860916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus.
    Rigas AN; Bittles AH; Hadden DR; Montgomery DA
    Br Med J; 1968 Oct; 4(5622):25-8. PubMed ID: 5677210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of acute intravenous loads of tolbutamide, acetohexamide and chlorpropamide in normal and diabetic subjects.
    Wajchenberg BL; Pereira VG; Pupo AA
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):143-7. PubMed ID: 5322748
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cholesterol, triglycerides and nonesterified fatty acids in the plasma of diabetic patients].
    Swynghedauw B
    Diabete; 1968; 16(1):40-4. PubMed ID: 5743941
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
    Ulrich E; Frank I; Kujat G; Müller G; Seige K
    Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the plasmatic concentration of non-esterified fatty acids during the intravenous tolbutamide test in the aged].
    Locatelli GR; Piotti LE
    G Gerontol; 1966 Oct; 14(10):961-8. PubMed ID: 5993793
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of dimethylbiguanide on various lipid blood levels in diabetic patients].
    Sgambato S; Cristiano L; Rufino G
    Rass Int Clin Ter; 1968 Jan; 48(1):27-32. PubMed ID: 5739935
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of the blood lipid pattern in diabetics under treatment with chlorpropamide and phenethyl-1-biguanide].
    Meduri D; Polito R
    Minerva Med; 1969 Jun; 60(49):2439-48. PubMed ID: 5802656
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chlorpropamide and other oral hypoglycemic agents in the treatment of diabetes mellitus resistant to tolbutamide. Clinico-statistical study].
    Danelon-Martina L
    Clin Ter; 1969 Apr; 49(2):135-46. PubMed ID: 5407314
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetes mellitus. Present concepts and therapeutic implications].
    de L'Hortet GC; Bercovici JP
    Presse Med (1893); 1968 Dec; 76(50):2389-92. PubMed ID: 5734286
    [No Abstract]   [Full Text] [Related]  

  • 17. Attempts to delay the progression of chemical diabetes.
    Jimenez JA; Oppermann W; De Lellis RH; Camerini-Dávalos RA
    Adv Metab Disord; 1970; 1():Suppl 1:421+. PubMed ID: 5446909
    [No Abstract]   [Full Text] [Related]  

  • 18. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.
    Chu PC; Conway MJ; Krouse HA; Goodner CJ
    Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations of the mechanism of action of the sulfonylureas under clinical conditions.
    Jackson WP; Van Mieghem W; Keller P
    Metabolism; 1973 Sep; 22(9):1155-62. PubMed ID: 4199277
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dynamics of blood serum lipid and lipoprotein indices in diabetes mellitus, treated with chlorpropamide and butamide].
    Sil'nitskiĭ PA
    Probl Endokrinol (Mosk); 1968; 14(3):9-13. PubMed ID: 5734589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.